These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34558729)

  • 1. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria.
    Liu R; Peng C; Jing D; Xiao Y; Zhu W; Zhao S; Zhang J; Chen X; Li J
    Exp Dermatol; 2022 Feb; 31(2):242-247. PubMed ID: 34558729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation.
    Song Y; Dan K; Yao Z; Yang X; Chen B; Hao F
    Front Cell Infect Microbiol; 2022; 12():831489. PubMed ID: 35372130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Refractoriness to an Up to Fourfold Dosage of Antihistamines in Isolated Chronic Spontaneous Urticaria.
    Wongjirattikarn R; Chaowattanapanit S; Foocharoen C; Sawanyawisuth K; Choonhakarn C; Julanon N; Utchariyaprasit E
    J Cutan Med Surg; 2022; 26(6):593-599. PubMed ID: 36172833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
    Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
    Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
    Ayse Ornek S; Orcen C; Church MK; Kocaturk E
    Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
    Altrichter S; Staubach P; Pasha M; Singh B; Chang AT; Bernstein JA; Rasmussen HS; Siebenhaar F; Maurer M
    J Allergy Clin Immunol; 2022 May; 149(5):1683-1690.e7. PubMed ID: 34954198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined microbiome and metabolome analysis of gut microbiota and metabolite interactions in chronic spontaneous urticaria.
    Luo Z; Jin Z; Tao X; Wang T; Wei P; Zhu C; Wang Z
    Front Cell Infect Microbiol; 2022; 12():1094737. PubMed ID: 36710970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
    Hon KL; Li JTS; Leung AKC; Lee VWY
    Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
    Bei W; Qian J; Zilu Q; Kai C; Ruili J; Feng H; Liuqing C
    Int Immunopharmacol; 2023 Oct; 123():110577. PubMed ID: 37567010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic improvement with colchicine in antihistamine- and omalizumab-resistant chronic spontaneous urticaria.
    Abe N; Bohgaki M; Kasahara H
    Clin Exp Dermatol; 2022 Dec; 47(12):2308-2310. PubMed ID: 36052842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Chronic Spontaneous Urticaria, Complete Response to Antihistamine Treatment Is Linked to Low Disease Activity.
    Türk M; Ertaş R; Şahiner ÜM; Kolkhir P; Şekerel BE; Soyer Ö; Avcı A; Atasoy M; Özyurt K; Türk Y; Zeydan E; Maurer M
    Int Arch Allergy Immunol; 2023; 184(5):421-432. PubMed ID: 36652936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome Alterations and Functional Prediction in Chronic Spontaneous Urticaria Patients.
    Zhang X; Zhang J; Chu Z; Shi L; Geng S; Guo K
    J Microbiol Biotechnol; 2021 May; 31(5):747-755. PubMed ID: 33746191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
    Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
    Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Control of CSU with Antihistamines Allows for Tolerance of NSAID-Exacerbated Cutaneous Disease.
    Sánchez J; Diez S; Cardona R
    J Allergy Clin Immunol Pract; 2020; 8(10):3577-3583.e1. PubMed ID: 32673879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine.
    Curto-Barredo L; Giménez-Arnau AM
    G Ital Dermatol Venereol; 2019 Aug; 154(4):444-456. PubMed ID: 30717573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in Gut Microbiota and Metabolism in Patients With Chronic Spontaneous Urticaria.
    Wang X; Yi W; He L; Luo S; Wang J; Jiang L; Long H; Zhao M; Lu Q
    Front Immunol; 2021; 12():691304. PubMed ID: 34721374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
    Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
    Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
    Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
    Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
    Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.